Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins.
about
Onto better TRAILs for cancer treatmentSuperior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivityAntitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein.EGFR-targeted TRAIL and a Smac mimetic synergize to overcome apoptosis resistance in KRAS mutant colorectal cancer cells.Hormesis, cell death and aging.Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily membersEnhancing the bystander killing effect of an oncolytic HSV by arming it with a secretable apoptosis activator.Cell death in disease: from 2010 onwardsFusion cytokine IL-2-GMCSF enhances anticancer immune responses through promoting cell-cell interactionsMembrane-proximal TRAIL species are incapable of inducing short circuit apoptosis signaling: Implications for drug development and basic cytokine biologyTargeted delivery of tumor necrosis factor-related apoptosis-inducing ligand to keratinocytes with a pemphigus mAb.An optimized antibody-single-chain TRAIL fusion protein for cancer therapy.Hypoxia regulates TRAIL sensitivity of colorectal cancer cells through mitochondrial autophagy.Role of the promyelocytic leukaemia protein in cell death regulation.Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants.ErbB2 dephosphorylation and anti-proliferative effects of neuregulin-1 in ErbB2-overexpressing cells; re-evaluation of their low-affinity interaction.Inhibition of autophagy significantly enhances combination therapy with sorafenib and HDAC inhibitors for human hepatoma cells.Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain format.Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications.Structural principles of tumor necrosis factor superfamily signaling.Pro-apoptotic effect of TRAIL-transfected endothelial progenitor cells on glioma cells.IgG-single-chain TRAIL fusion proteins for tumour therapy.Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells.
P2860
Q26768160-596EF03E-ED6A-4AEA-A507-EAB5DBC4B3C4Q28729760-BB69A90D-2945-430A-8C03-243382B85E0AQ33658976-D80EDEA0-1FB5-48BC-A71D-6B1038246C40Q34149887-4E2A24CD-824D-4A95-88AD-E2ED25024475Q34217654-C33062F0-CCBB-41F9-BB7A-733CEBD43A9AQ34386821-18F1C1CF-1F97-4479-9C93-91428FF3B766Q35154965-5EA0116E-F6AD-4A9F-B839-13403B9B6600Q35269870-50696D73-F463-41CF-841D-CA94CE24265CQ36550399-90E570F4-AA5A-4447-9218-25ED7F9BD2CDQ36645343-EA0ED97B-F715-4029-B20D-7525A362C522Q36927030-6D16FF9E-8FF5-4F8E-ABF7-F911223AF9D6Q37141627-A308E48B-1D85-48E3-AAF8-20AC07BBF87DQ37520269-B45009E2-2C83-4261-A354-FC6704FC73AFQ37975087-324A3A86-9632-4FDC-8FAB-D30CD1987285Q38120535-44B4A570-3C4A-4A98-A441-89A815AD9D3EQ39028796-D0250561-7A0C-44A2-BF0E-16603073C2E1Q39184409-7613A60A-DBE4-418A-983D-602FC98FB86DQ39206134-BCDEF302-CE54-43A3-BA23-8A833519204BQ41686962-C51036B4-B6B8-4675-A870-C19973000628Q42632659-552A4C1B-1084-445F-A29A-DF1E88425DDDQ48319204-04C91D6D-9271-438A-AD0F-90E9AD6831C9Q52653034-04179F18-1008-49C0-938A-D3C147AA2EA2Q54998541-D800713A-9D3E-463C-BA15-C6770456C71AQ55012569-ABD8DDA0-6E09-4890-BC50-37CAA570563B
P2860
Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Potent antitumoral activity of ...... single-chain fusion proteins.
@ast
Potent antitumoral activity of ...... single-chain fusion proteins.
@en
Potent antitumoral activity of ...... single-chain fusion proteins.
@nl
type
label
Potent antitumoral activity of ...... single-chain fusion proteins.
@ast
Potent antitumoral activity of ...... single-chain fusion proteins.
@en
Potent antitumoral activity of ...... single-chain fusion proteins.
@nl
prefLabel
Potent antitumoral activity of ...... single-chain fusion proteins.
@ast
Potent antitumoral activity of ...... single-chain fusion proteins.
@en
Potent antitumoral activity of ...... single-chain fusion proteins.
@nl
P2093
P2860
P356
P1476
Potent antitumoral activity of ...... d single-chain fusion proteins
@en
P2093
A Krippner-Heidenreich
B Schneider
I Grunwald
J Gerspach
K Pfizenmaier
P2860
P356
10.1038/CDDIS.2010.45
P577
2010-08-26T00:00:00Z